Form submitted successfully. Thank you. You may access the webinars below.
COVID and beyond: NGS applications for public health surveillance, epidemiology, and emerging pathogen identification
Eugene Yeboah
Sr. Scientist, The Association of Public Health Laboratories
Targeted sequencing of large and small viruses
Dr. Dirk Dittmer
Director, Vironomics Core, The University of North Carolina, Chapel Hill
Development and application of environmental genomics in ecological environment monitoring and management
Dr. Zhang Xiaowei
Professor, Nanjing University, Nanjing, Jiangsu, China
Ion AmpliSeq White Glove Service: Custom NGS solutions for infectious disease research
Dr. Giorgio Pea
Product Manager, Thermo Fisher Scientific
Ecogenomics: whole-genome SARS-CoV-2 wastewater AmpliSeq multi-sample analysis
Roger Levesque, Ph.D.
Founder, Integrative and Systems Biology Institute, Université Laval, Québec, Canada
SARS-CoV-2 testing and variants' surveillance in the Indian Scenario
Potdar Varsha Atul, Ph.D., MSc
Head National Influenza Centre, ICMR National Institute of Virology, Pune, India
The utility of SARS-CoV-2 genome sequencing on the Ion Torrent Genexus Platform
Sixto M. Leal Jr., MD, PhD
Director, Clinical Microbiology, The University of Alabama at Birmingham
Advances in Next-Generation Sequencing for the identification and characterization of viral pathogens
Rob Schuurman, PhD
Head of Molecular Diagnostics, Department of Virology, University Medical Centre Utrecht, Netherlands
Syndromic testing by targeted next-generation sequencing: Detection of infectious diseases of animals from clinical samples
Rebecca Wilkes, DVM, PhD
Associate Professor, Molecular Diagnostics; Section Head for Molecular and Virology; Purdue University
Emergence and spread of variants of SARS-CoV-2 in SA and Africa
Prof. Tulio de Oliveira, PhD
Professor of Bioinformatics: School for Data Science and Computational Thinking; Faculty of Science and Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa
Mako Medical: Rapidly Expanding SARS-CoV-2 Sequencing Capacity to Support CDC Efforts
Matt Tugwell
Director, Genomics, Mako Medical, USA
SARS-CoV-2 complete genome sequencing research from the Japan Osaka region using Ion Torrent Genexus Integrated Sequencer
Dr. Narumi Ueda
Assistant Professor, Department of Orthopaedic Surgery, Kansai Medical University Medical Center, Japan
SARS-CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high-risk variants into the United Kingdom
Dr. Marco Loddo
Co-Founder and Scientific Director, Oncologica UK Ltd, UK
Pivoting from cancer to COVID-19 in a global pandemic
Prof. Dr. Paul Hofman
Head of the Laboratory of Clinical and Experimental Pathology at the University Hospital Nice, France
Implementation of SARS-CoV2 NGS analysis at Amsterdam UMC
Dr. Ir. Marcel Jonges
Laboratory Head of Medical Microbiology and Infection Prevention, Amsterdam UMC, The Netherlands
SARS-CoV-2 variants: Role of real-time genomic sequencing in COVID-19 response
Dr. Barbara Bartolini
Senior Scientist at Microbiology Laboratory and Infectious Diseases Biorepository at the National Institute for Infectious Diseases "L. Spallanzani" (INMI), Rome, Italy
One year of SARS-CoV-2 surveillance in wastewater
Dr. Ing. Shelesh Agrawal
Microbiology Group Leader, Technical University of Darmstadt, Institut IWAR, Germany
Featured Ion Torrent NGS solutions for SARS-CoV-2 research
Rapid sequencing of the complete SARS-CoV-2 genome for epidemiology research
The Ion AmpliSeq SARS-CoV-2 Research Panel for the Genexus Integrated Sequencer enables complete viral genome sequencing and variant detection of SARS-CoV-2 with >99% coverage. Rapidly go from nucleic acid to variant report in under a single day with minimal hands-on time. Bring simple, practical NGS to your lab. Learn more
Comprehensive, end-to-end immunology solutions for vaccine research
Ion Torrent targeted NGS provides a multi-dimensional approach to repertoire sequencing and immune response, enabling a deeper understanding of the adaptive immune system and its role in human health and response to infection and vaccines. Each assay is part of an end-to-end workflow that includes simple data analysis tools so you can focus on the biological meaning of your data.
Discover our solutions for vaccine research and study additional factors that influence host genetics and immune pathways:
- TCR and BCR sequencing
- Microbiome analysis
- Gene expression and transcriptome analysis
